Table 1. Patient demographics.

Clinicopathological parameters	No metastasis, N=135	Confirmed metastasis, N=17	P
Age (years)	63 [19–84]	55 [22–82]	0.050
Male: female	107:28	15:2	0.580
Hepatitis B	97 [72]	16 [94]	0.140
Hepatitis C	7 [5]	0 [0]	0.516
Comorbidity	70 [52]	7 [41]	0.407
Child-Pugh class			0.005*
A	114 [84]	9 [53]
B	17 [13]	7 [41]
C	3 [2]	0 [0]
ICG (%)	10.5 (4.9–46.5)	12.8 (5.0–21.9)	0.813
Bilirubin (μmol/L)	11 [4–100]	14 [5–39]	0.273
Albumin (g/L)	39 [23–51]	35 [26–42]	0.203
Platelet (×109/L)	178 [36–693]	222.5 [63–524]	0.013*
Creatinine (μmol/L)	84 [40–283]	74 [53–141]	0.923
Size of largest tumor (cm)	5 (1.0–22.1)	11.8 (2.3–20.0)	0.003*
Disease pattern			0.008*
Solitary	78 [58]	4 [24]
Multifocal	57 [42]	13 [76]
Bilobar involvement	41 [30]	12 [71]	0.001*
AFP			0.002*
<400 ng/mL	101 [75]	6 [35]
≥400 ng/mL	33 [24]	11 [65]
Invasion of major branch of portal or hepatic vein	21 [16]	5 [29]	0.277

Data in median [range] or number of patients [percent] or otherwise stated. *, statistically significant. ICG, indocyanine green retention rate at 15 minutes after injection; AFP, alpha-fetoprotein.